MX2017001192A - Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun. - Google Patents

Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.

Info

Publication number
MX2017001192A
MX2017001192A MX2017001192A MX2017001192A MX2017001192A MX 2017001192 A MX2017001192 A MX 2017001192A MX 2017001192 A MX2017001192 A MX 2017001192A MX 2017001192 A MX2017001192 A MX 2017001192A MX 2017001192 A MX2017001192 A MX 2017001192A
Authority
MX
Mexico
Prior art keywords
allopathies
treatment
pharmaceutical composition
oral administration
loratadine
Prior art date
Application number
MX2017001192A
Other languages
English (en)
Inventor
Daniel Walls Flores Oliver
Rodríguez Hernández Ramón
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2017001192A priority Critical patent/MX2017001192A/es
Priority to PCT/IB2018/050431 priority patent/WO2018138652A1/es
Publication of MX2017001192A publication Critical patent/MX2017001192A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención consiste en la preparación de una composición farmacéutica con un agente antihistamínico, con un agente descongestionante, con un agenta antipirético/analgésico y un agente antiviral en una administración oral para el tratamiento de alopatías referente al resfriado común.
MX2017001192A 2017-01-26 2017-01-26 Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun. MX2017001192A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2017001192A MX2017001192A (es) 2017-01-26 2017-01-26 Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.
PCT/IB2018/050431 WO2018138652A1 (es) 2017-01-26 2018-01-24 Composición farmacéutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatías relacionadas a un resfriado comun

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017001192A MX2017001192A (es) 2017-01-26 2017-01-26 Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.

Publications (1)

Publication Number Publication Date
MX2017001192A true MX2017001192A (es) 2018-07-25

Family

ID=62979398

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001192A MX2017001192A (es) 2017-01-26 2017-01-26 Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.

Country Status (2)

Country Link
MX (1) MX2017001192A (es)
WO (1) WO2018138652A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US8603523B2 (en) * 2005-06-17 2013-12-10 Aft Pharmaceuticals Limited Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
MX2009001925A (es) * 2009-02-20 2010-08-20 Senosiain S A De C V Lab Composicion farmaceutica oral para uso en enfermedades respiratorias.
MX2015007749A (es) * 2015-06-17 2016-12-16 Laboratorios Liomont S A De C V Composicion farmaceutica de clorhidrato de amantadina-loratadina-p aracetamol para integrar una capsula, para el tratamiento de resfriados entre otras alopatias.

Also Published As

Publication number Publication date
WO2018138652A1 (es) 2018-08-02

Similar Documents

Publication Publication Date Title
MY196173A (en) Cot Modulators And Methods Of Use Thereof
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
PE20151301A1 (es) Formulaciones farmaceuticas resistentes a la manipulacion indebida
MX2018000546A (es) Composiciones farmaceuticas que contienen celecoxib y tramadol.
MX2021002321A (es) Nuevos metodos.
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
MX2021004883A (es) Metodos y composiciones para tratar apnea del sue?o.
DOP2015000089A (es) Composición de difenidol de liberación prolongada
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12018500817A1 (en) Pharmaceutical composition comprising metformin and lobeglitazone
WO2015166419A3 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
MX2018002681A (es) Agente mejorador de la inmunidad contra el cancer por el antagonista de "allergin-1".
MX2017001192A (es) Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun.
MA31227B1 (fr) Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
AU2018333952A1 (en) Methods and compositions to inhibit symptoms associated with opioid withdrawal
IN2013MU03428A (es)
MX2018015759A (es) Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo.
CO2019013645A2 (es) Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas
GT201500333A (es) Composición farmacéutica sinergística de dos analgésicos con distinto perfil famacocinético
UA107884C2 (en) Combined anti-tuberculosis drug
MX2015009504A (es) Composicion farmaceutica de desloratadina para ser administrada por via oral, para el tratamiento de enfermedades relacionadas con la histamina.
MX2016011140A (es) Composiciones sinergisticas de aminas simpaticomimeticas, 5-hidroxitriptofano y carbidopa para la perdida de peso.
CL2015003409A1 (es) Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético